Share
ISSN: 1889-1837
Indexed in:
Web of Science, Index Medicus/MEDLINE, SCOPUS, IBECS, IME
See moreFollow us:
Subscribe:
Impact factor
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2022
Impact factor 2023
1.2
Citescore 2023
1.7
SJR
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
See moreSJR 2023
0.234
SNIP
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
See moreSNIP 2023
0.46
View more metrics
Hide
Articles in press
Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info
RESUMENS
Available online 14 June 2024
Vitamin D3 supplementation in COVID-19 patients with cardiovascular disease and gut dysbiosis
R.L. Sanz, F. García, A. Gutierrez, S. García Menendez, F. Inserra, L. Ferder, W. Manucha
Available online 13 June 2024
.
Available online 13 June 2024
View all Ahead of print
Current Issue
Editorial
Hypertension and Vascular Risk already has an impact factor. Now a new challenge begins
P. Armario, E. Vinyoles, T. Gijon-Conde, C. Arranz, J.M. Galceran
Hipertens Riesgo Vasc. 2024;41:73-4
Is proteinuria an important fact concerning the nephroprotective effect of renin-angiotensin system inhibitors?
J.M. Galceran
Hipertens Riesgo Vasc. 2024;41:75-7
Originales
Estudio de prevalencia, conocimiento y control de la hipertensión arterial en barrios vulnerables de Argentina
W.G. Espeche, M. Marin, C. Romero, N. Renna, S. Vissani, G. Blanco, S.P. Pantalena, D. Cesario, ... M.R. Salazar
Hipertens Riesgo Vasc. 2024;41:78-86
Type 2 diabetes patients requiring empagliflozin in Southeast of Iran: Frequency and guideline adherence (2022–2023)
S.M. Khoshnazar, A. Dehghani, F. Bagheri, S. Pezeshki, G. Yousefzadeh
Hipertens Riesgo Vasc. 2024;41:87-94
View all issue
Free access article
Review
Diuretics use in the management of hypertension
F.J. Morales-Olivas
10.1016/j.hipert.2024.03.004
Archive
January - March
Volume 41 . Issue. 1
Pages 1-72
October - December
Volume 40 . Issue. 4
Pages 167-234
July - September
Volume 40 . Issue. 3
Pages 107-166
April - June
Volume 40 . Issue. 2
Pages 55-106
View all archive
Supplements
April
Volume 41. Issue. S1
Documento de consenso sobre tabaquismo y riesgo vascular
Pages I-II
Pages S1-S85
Pages S1-S85
April
Volume 41. Issue. S1
Pages S1-S85
March
Volume 36. Issue. SC
24.ª Reunión Nacional de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial. 11.ª Reunión de Investigación en Fisiopatología Vascular
Pages 1-48
March
Volume 35. Issue. SC
23.ª Reunión Nacional de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial
Pages 1-60
View all supplements
Instructions for authors
Publish in Hipertensión y Riesgo Vascular
- Instructions for authors
- Submit an article
- Ethics in publishing
- Diversity pledge
- Open Access Option
- Language Editing services
Most often read
CASO CLÍNICO
M.P. Pérez García, J.F. García Granado, F.J. Martínez Martín
10.1016/j.hipert.2023.09.002
Hipertens Riesgo Vasc. 2024;41:62-5
This article has been read 322 times
View all Most Often read articles